Pharmaceuticals, Biotechnology and Life Sciences
— The PATHFINDER Study will Return GRAIL’s Test Results to Providers for the First Time — — First Participants Successfully…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pandion Therapeutics, a privately-held biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that company management…
DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance World 2020” conference has been added to ResearchAndMarkets.com’s offering. With the augmented incidence of diseases, and the…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trials Connect 2020” conference has been added to ResearchAndMarkets.com’s offering. The 4th Annual Global Clinical Trials…
DUBLIN–(BUSINESS WIRE)–The “Digi-Tech Pharma & AI 2020” conference has been added to ResearchAndMarkets.com’s offering. The 4th Annual Digi-Tech Pharma &…
Can Fite has out licensed Namodenoson for the treatment of NASH to CKD in Korea PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma…
– HELIOS-A Topline Results Expected in Early 2021 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…
Pivotal Phase 3 trial of zilucoplan in gMG ongoing, with top-line results expected in early 2021 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ra Pharmaceuticals,…
DUBLIN, Ireland & BURLINGAME, Calif.–(BUSINESS WIRE)–ALX Oncology, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today…
GERMANTOWN, Maryland–(BUSINESS WIRE)–Precision Molecular, Inc. (PMI), a clinical-stage company with the mission to develop imaging biomarkers and theranostics, today announced…